0001209191-14-060597.txt : 20141001
0001209191-14-060597.hdr.sgml : 20141001
20141001171844
ACCESSION NUMBER: 0001209191-14-060597
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140930
FILED AS OF DATE: 20141001
DATE AS OF CHANGE: 20141001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horton Kenneth L
CENTRAL INDEX KEY: 0001552047
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 141133912
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-09-30
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001552047
Horton Kenneth L
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP & Chief Legal Officer
Common Stock
2014-09-30
4
M
0
36000
55.83
A
68463
D
Common Stock
2014-09-30
4
S
0
4713
111.33
D
63750
D
Common Stock
2014-09-30
4
S
0
14286
112.22
D
49464
D
Common Stock
2014-09-30
4
S
0
9601
113.10
D
39863
D
Common Stock
2014-09-30
4
S
0
7400
113.91
D
32463
D
Common Stock
366
I
401(k)
Stock Option (right to buy)
55.83
2014-09-30
4
M
0
36000
0.00
D
2022-06-10
Common Stock
36000
36000
D
Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $111.33 (range $110.61 to $111.60).
Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $112.22 (range $111.61 to $112.60).
Open market sales reported on this line occurred at a weighted average price of $113.10 (range $112.61 to $113.60).
Open market sales reported on this line occurred at a weighted average price of $113.91 (range $113.62 to $114.41).
The option vests in 16 quarterly installments from 06/11/2012.
Kenneth L. Horton
2014-10-01